
|
News
|

|
Results for the six months ended 30 September 2022
Read more
Investor Presentation covering Interim Results
Read more
Partnership with Moredun Research Institute – Poultry Red Mite Vaccine
Read more
ECO Animal Health Group plc in partnership with Imperial College London
Read more
ECO RECIEVES TWO NEW MARKETING AUTHORISATIONS FOR AIVLOSIN® IN CHINA
Read more
New Aivlosin® WSG M. hyopneumoniae claim in USA & Canada
Read more
Brazilian Marketing Authorisation for Swine Vaccine Circo/MycoGard®
Read more
ECO signs two PRRSV vaccine development and licencing deals
Read more
European marketing authorisation for Aivlosin® WSG in pigs for treatment and metaphylaxis of M. hyopneumoniae
Read more
Marketing authorisation in Indonesia received for Aivlosin®/Valosin® WSG in chickens laying eggs
Read more
ECO and The Pirbright Institute sign second poultry vaccine development licensing deal
Read more
ECO and The Pirbright Institute sign novel poultry biopharmaceutical development licensing deal
Read more
ECO and Ghent University Sign Poultry Vaccine Development Licencing Deal
Read more
ECO and University of Georgia sign second poultry vaccine development licencing deal for Mycoplasma synoviae vaccine
Read more
ECO and Agrinnovation (Yissum) LP sign swine antimicrobial novel formulation development & licensing deal
Read more
ECO and University of Georgia sign poultry vaccine development licencing deal
Read more
This website uses cookies to improve your experience. If you continue to use this site, you agree with it.